nitrosobis(2-oxopropyl)amine and sulindac

nitrosobis(2-oxopropyl)amine has been researched along with sulindac in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badve, S; Gage, EA; Saxena, R; Schmidt, CM; Wentz, SC; Yip-Schneider, MT	1

Other Studies

1 other study(ies) available for nitrosobis(2-oxopropyl)amine and sulindac

Article	Year
Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo. The Journal of surgical research, 2009, Volume: 157, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts; Bile Ducts, Intrahepatic; Carcinogens; Cell Division; Cholangiocarcinoma; Cricetinae; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Female; I-kappa B Proteins; Mesocricetus; NF-KappaB Inhibitor alpha; Nitrosamines; Sulindac; Transcription Factor RelA	2009

Article

Year

Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo.

The Journal of surgical research, 2009, Volume: 157, Issue:1

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts; Bile Ducts, Intrahepatic; Carcinogens; Cell Division; Cholangiocarcinoma; Cricetinae; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Female; I-kappa B Proteins; Mesocricetus; NF-KappaB Inhibitor alpha; Nitrosamines; Sulindac; Transcription Factor RelA

2009